Astrazeneca PLC

(AZN) Trade

By |

Profile

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology, and neuroscience. The majority of sales come from international markets with the United States representing almost 30% of its sales.

Contact Information

Website: www.astrazeneca.com
Email: ir@astrazeneca.com
Main Phone: +44 2037495000
Address: 1 Francis Crick Avenue
Address 2: Cambridge Biomedical Campus
City / Town: Cambridge
Country: GBR
Postal Code: CB2 0AA

Issuer Information

Exchange: NYE
CEO: Pascal Soriot
Employees: 61100
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 38.41 $ 0.23 (0.60%)
Last Price 38.41 Change $ 0.23 Change % 0.60 Tick N/A
Bid 37.00 Bid Size 100.00 Ask 39.39 Ask Size 100.00
Open 38.86 High 38.86 Low 38.13 Prev Close 38.18
Last Trade Volume 6.8 mi 52 Wk Hi 41.78 52 Wk Low 32.69
Market Cap 97.3 bi Ex-Div Date Div Rate 0.90 Yield 2.3430
Shares 2,533,623,406.00 EPS (TTM) 0.96 PE Ratio 39.90 Exchange NYSE
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 42 42 42 42
Low Target Price Estimate 37 37 37 37
Mean Target Price Estimate 38.85 38.85 38.85 38.85
Standard Deviation 2.18 2.18 2.18 2.18
Date of Most Recent Estimate 05/18/18 05/18/18 05/18/18 05/18/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 7 7 6
Moderate Buy 0 0 0 0
Hold 1 1 1 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.25 1.25 1.25 1.8